FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/05/053082 [Registered on: 23/05/2023] Trial Registered Prospectively
Last Modified On: 23/05/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Other 
Public Title of Study   This study is to understand how different causation of Psoriasis helps in deciding the management plans The two scales PASI and DQLI scale will help in assessing the response. 
Scientific Title of Study   EXPLORING THE ROLE OF DIFFERENT CAUSATION IN PLANNING MANAGEMENT STRATEGY OF PSORIASIS ASSESSING THE RESPONSE WITH THE HELP OF PASI ( PSORIASIS AREA AND SEVERITY INDEX ) & DLQI (DERMATOLOGY LIFE QUALITY INDEX ) SCALES EXPERIMENTAL UNCONTROLLED STUDY 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrShama Manoj Rao 
Designation  Professor Dept of Practice of Medicine 
Affiliation  Dr.M.L.Dhawale Memorial Homoeopathic Institute 
Address  Dr M L Dhawale Memorial Homoeopathic Institute Boisar Road Opposite S T stand Palghar 401404
Dr M L Dhawale Memorial Homoeopathic Institute Boisar Road Opposite S T stand Palghar 401404
Thane
MAHARASHTRA
401404
India 
Phone  9892212843  
Fax    
Email  rao.shama@rediffmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Hitesh G Purohit 
Designation  Principal and Professor and HOD Department of Materia Medica 
Affiliation  Smt Malini Kishore Sanghvi Homoeopathic Medical College 
Address  Smt Malini Kishore Sanghvi Homoeopathic Medical College Karjan Opposite Sumeru Navkar Tirth Amod Road Miyagam Karjan Vadodara 391240
Smt Malini Kishore Sanghvi Homoeopathic Medical College Karjan Opposite Sumeru Navkar Tirth Amod Road Miyagam Karjan Vadodara 391240
Vadodara
GUJARAT
391240
India 
Phone  9376939622  
Fax    
Email  drhiteshp@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrShama Manoj Rao 
Designation  Professor Dept of Practice of Medicine 
Affiliation  Dr.M.L.Dhawale Memorial Homoeopathic Institute 
Address  201 A wing Alok Apartment Mahant Road Vile Parle East Mumbai 400057
Dr M L Dhawale Memorial Homoeopathic Institute Boisar Road Opposite S T stand Palghar 401404
Thane
MAHARASHTRA
400057
India 
Phone  9892212843  
Fax    
Email  rao.shama@rediffmail.com  
 
Source of Monetary or Material Support  
Dr M L Dhawale Memorial Homoeopathic Institute Palghar Boisar Road Opposite S T Workshop Palghar 401404 Maharashtra India 
 
Primary Sponsor  
Name  Dr M L Dhawale Memorial Homoeopathic Institute 
Address  Dr M L Dhawale Memorial Homoeopathic Institute Boisar Road Opposite S T Stand Palghar 401404  
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shama Rao  Dr M L Dhawale Memorial Homoeopathic Institute  Boisar Road Opposite S T Stand Palghar 401404 Ground Floor OPD Number 135 Department Of Practice Of Medicine Room Number 5 Second Floor
Thane
MAHARASHTRA 
9892212843

rao.shama@rediffmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Smt Malini ishore Sanghvi Homoeopathic Medical College & Hospital Karjan Vadodara   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L400||Psoriasis vulgaris,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  HOMOEOPATHIC INDICATED MEDICINE FOR EACH INDIVIDUAL PATIENT AFTER DETAILED CASE TAKING OF EACH OF THEM AS THE MEDICATIONS MAY VARY DEPENDING ON THE SYMPTOMS OF EACH INDIVIDUAL PATIENT Indicated Homoeopathic Acute or Chronic or Intercurrent medicine  Indicated Homoeopathic Acute or Chronic or Intercurrent medicine Dose potency 200. One dose per week will be used to start with for first thee months. As per the response Repetation may be reviewed. Route of administration would be oral Duration of therapy 18 months.  
Comparator Agent  NOT APPLICABLE  NOT APPLICABLE 
 
Inclusion Criteria  
Age From  10.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  All patients belonging to all sex and age group from 10 to adult.
Cases of Psoriasis where the remedy has registered its action assessed by adequate subjective and objective parameters (Scales attached)
Cases of Psoriasis with minimum 6 months of follow up
Patients on allopathic medication already but willing to stop that & shift to Homoeopathy & continue Homoeopathic treatment. If patient is on steroids washout period will not be applicable. Sudden stopping of local or systemic steroids will not become possible in any patient as it may lead to sudden increase in intensity of symptoms. So slowly tapering will have to be done. The tapering of allopathic medications will be done with the help of M.D. Physician. If any other applications like Salysalic acid cream, then no washout period. 
 
ExclusionCriteria 
Details  If high doses of systemic steroids or Methotrexate given for long duration
Patients suffering from other autoimmune diseases
Patients on immunosuppressive therapies e.g. chemotherapy for cancer
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Possible management strategies in different presentations of Psoriasis based on Fundamental or Precipitating or Maintaining causation  2 years 6 months 
 
Secondary Outcome  
Outcome  TimePoints 
This study will contribute to expand & sharpen Homoeopathic Materia Medica knowledge as some conclusions can be drawn after studying various cases of psoriasis   2 years 9 months 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/07/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not Applicable 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Recruitment of samples will start approximately from 15 th February 2023 after the CTRI approval
Samples will be chosen as per inclusion & exclusion criteria 
Samples will be taken from MLDMHI centers
 
Close